Early-phase Trial to Assess the Safety and Preliminary Efficacy of BNT3214 in Adults With Advanced Solid Tumors

Clinical trial NCT07455734 · RECRUITING

Trial details

NCT number: NCT07455734
Sponsor: BioNTech SE
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Advanced Solid Tumor Cancer

Start date: 2026-03-30
Primary completion: 2030-10-01
Enrollment: 533

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.